4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Ortin Global Limited (ORTINGLOBE) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Hyderabad, India with about 8 employees. Its market capitalization is roughly ₹129 million. In the fiscal year ended 2026-03-31, ORTINGLOBE reported ₹1M in revenue and (₹7M) in net income.
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | ₹1M | ₹3M | ₹21M | ₹60M |
| Gross Profit | ₹0M | ₹1M | (₹16M) | ₹26M |
| Operating Income (EBIT) | (₹10M) | (₹9M) | (₹45M) | ₹3M |
| Net Income | (₹7M) | (₹8M) | (₹80M) | (₹1M) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | ₹0M | ₹0M | ₹0M | ₹0M | ₹0M | — | — |
| Gross Profit | ₹0M | ₹0M | ₹0M | ₹0M | (₹0M) | — | — |
| Operating Income (EBIT) | (₹3M) | (₹0M) | (₹0M) | (₹5M) | (₹2M) | — | — |
| Net Income | (₹3M) | (₹0M) | (₹0M) | (₹5M) | (₹2M) | — | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹46M | ₹38M | ₹67M | ₹212M | — |
| Total Liabilities | ₹34M | ₹18M | ₹38M | ₹103M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ORTINGLOBE viewer.
About TickerBase · Data methodology & sources · Privacy · Terms